Editorial Feature:

Treatment Adherence in Neovascular AMD

Adding the missing link in successful outcomes with next generation treatment options.

In this Feature

Return of Fluid Results in Failure to Extend

Carl D. Regillo, MD

Taking Your Foot Off the Gas

Rishi P. Singh, MD

Implications of Missed Anti-VEGF Doses

Caroline R. Baumal, MD

A Clinical Biomarker of AMD Activity?

Rishi P. Singh, MD

Evolving Treatment Standards in nAMD

Caroline R. Baumal, MD

Treat and Extend: When it Works, When it Doesn’t, and a Potential Role for PRN

Usha Chakravarthy, MD, PhD

Interactive Supplements

Treatment Adherence in Neovascular AMD

Read Supplement

Listen as a Podcast

New Retina Radio

All video episodes of this series are also available as podcast episodes on New Retina Radio.

Listen Now

About This Editorial Feature

Carl Regillo, MD, moderates a roundtable discussion with Caroline Baumal, MD; Usha Chakravarthy, MD, PhD, CBE; and Rishi Singh, MD; that addresses the modern challenges of treatment adherence in patients with neovascular age-related macular Degeneration. Dr. Regillo and the roundtable participants address questions of real-world safety, summarize late-phase and early-phase clinical trial data, and share cases of challenging patients.